Zika paper-based rapid diagnostic test

Dr. Keith Pardee

A paper-based diagnostic device to detect viral threats

Product description Brand name and product description

A Zika paper-based diagnostic device is a molecular diagnostic tool embedded into paper that uses blood, urine or saliva to provide results in a short time. It is composed of three components: An amplifier for the genetic sequences found in the patient sample; a toehold switch sensor to recognize if the sequences found are from Zika virus, and a third component to determine the strain of the virus. This product is still a proof of concept, and additional testing is needed to ensure safety and efficacy before actual deployment.


Target region(s) Target region for distribution/implementation (listed by country if specified)

Regions vulnerable to this pandemic threat (South America, Central America and the Caribbean – Countries: Brazil, Colombia, Puerto Rico)

Distributors/implementing organizations Organization(s) distributing/deploying this product directly to communities/individuals?"


Market suggested retail price Price per unit or service price per usage/terms (USD). Subsidies noted.

Paper tests cost less than a 1 USD, electronic optical reader approximately 250 USD.

Competitive landscape Similar products available on the market. May not be a comprehensive listing.

ZIKV Detect™ 2.0 IgM Capture ELISA is the only product validated by the FDA for Zika diagnosis.

SDG targeted United Nations Sustainable Development Goals (SDGs) targeted with this product/application/service

Goal 3: Good health and well-being

Target user(s) Target user/consumer base (country, income segment)

Trained healthcare professionals in need of rapid diagnostic tools

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F